Washington · 2025–26 Regular Sessions · Bill

HB 2145: 340B drug pricing program

In committee Last action February 9, 2026: Referred to Rules 2 Review.

Plain-language summary

HB 2145 is a bill introduced in the Washington House on December 15, 2025. According to its official title, it concerns: Protecting patient access to discounted medications and health care services through Washington's health care safety net by preventing manufacturer limitations on the 340B drug pricing program. Primary sponsor: My-Linh Thai (D). It lists 40 additional sponsors. Most recent recorded action (February 9, 2026): Referred to Rules 2 Review.

Sponsors

Primary sponsor: My-Linh Thai (Democratic). 40 co-sponsors.